Dovato 50 mg/300 mg film-coated tablets, Biktarvy 50 mg/200 mg/25 mg film-coated tablets
219816
Phase 3 small_molecule active
Quick answer
Dovato 50 mg/300 mg film-coated tablets, Biktarvy 50 mg/200 mg/25 mg film-coated tablets for Human immunodeficiency virus (HIV) is a Phase 3 program (small_molecule) at ViiV Healthcare BV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ViiV Healthcare BV
- Indication
- Human immunodeficiency virus (HIV)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active